BiomX Inc. - Common Stock, $0.0001 par value per share (PHGE)

CUSIP: 09090D103

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 6 signals
Share change
-17,901
SEC-reported price per share
$0.34
Indexed holders
14
Value change
-$5,123
Number of buys
6
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
11,618,400

Security key

09090D103

Report period

Q3 2022

Indexed institutions

14

Top holders

9

Ownership snapshot

Top reported holders of PHGE - BiomX Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/13
Latest evidence
30 Jun 2022
13F 3/4/5 Highest disclosed value: $2,054,000 13 rows are not safely comparable across share classes. Showing 1-6 of 13 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $2.05M.

0 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
ORBIMED ADVISORS LLC $2.05M
JOHNSON & JOHNSON $1.56M
MMCAP International Inc. SPC $500K
ROYCE & ASSOCIATES LP $240K
MILLENNIUM MANAGEMENT LLC $58K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 13 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$2,054,000
2,813,489 shares
— 30 Jun 2022
JOHNSON & JOHNSON
13F
Company
13F
—
denominator unverified
$1,557,000
2,133,402 shares
— 30 Jun 2022
MMCAP International Inc. SPC
13F
Company
13F
—
denominator unverified
$500,000
684,451 shares
— 30 Jun 2022
ROYCE & ASSOCIATES LP
13F
Company
13F
—
denominator unverified
$240,000
328,655 shares
— 30 Jun 2022
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$58,000
78,933 shares
— 30 Jun 2022
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$43,000
58,700 shares
— 30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
14
Shares
6,160,749
Indexed holders
14
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 indexed holders
10
Q3 2022 indexed holders
14
Indexed holder difference
4
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .